$EXEL
EXELIXIS, INC.

2022 Q4 Form 10-Q Financial Statement

#000093976722000110 Filed on November 01, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $423.9M $411.7M
YoY Change 29.08% 6.9%
Cost Of Revenue $15.92M $15.31M
YoY Change 34.07% 2.83%
Gross Profit $408.0M $396.4M
YoY Change 28.89% 7.06%
Gross Profit Margin 96.24% 96.28%
Selling, General & Admin $119.3M $115.0M
YoY Change 17.42% 16.74%
% of Gross Profit 29.23% 29.0%
Research & Development $336.8M $198.8M
YoY Change 106.17% 33.64%
% of Gross Profit 82.56% 50.16%
Depreciation & Amortization $5.946M $5.663M
YoY Change 207.92% 17.88%
% of Gross Profit 1.46% 1.43%
Operating Expenses $456.1M $313.8M
YoY Change 72.15% 26.91%
Operating Profit -$48.08M $82.61M
YoY Change -193.14% -32.84%
Interest Expense $16.99M $9.498M
YoY Change 1078.9% 472.86%
% of Operating Profit 11.5%
Other Income/Expense, Net -$337.0K -$69.00K
YoY Change 1673.68% 527.27%
Pretax Income -$31.43M $92.04M
YoY Change -126.63% -26.3%
Income Tax -$1.254M $18.83M
% Of Pretax Income 20.46%
Net Earnings -$30.17M $73.21M
YoY Change -178.98% -23.81%
Net Earnings / Revenue -7.12% 17.78%
Basic Earnings Per Share $0.23
Diluted Earnings Per Share -$0.09 $0.23
COMMON SHARES
Basic Shares Outstanding 322.6M shares 322.1M shares
Diluted Shares Outstanding 325.1M shares

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.308B $1.547B
YoY Change -10.81% 10.28%
Cash & Equivalents $501.2M $675.3M
Short-Term Investments $807.3M $871.7M
Other Short-Term Assets $62.21M $52.90M
YoY Change 8.14% 2.6%
Inventory $33.30M $26.71M
Prepaid Expenses
Receivables $214.8M $215.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.619B $1.842B
YoY Change -11.77% 15.59%
LONG-TERM ASSETS
Property, Plant & Equipment $110.6M $107.9M
YoY Change 6.34% 13.43%
Goodwill $63.68M $63.68M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $756.7M $550.3M
YoY Change 103.91% 66.21%
Other Assets $520.0M $280.0M
YoY Change 296.96% 107.52%
Total Long-Term Assets $1.453B $1.120B
YoY Change 85.89% 44.67%
TOTAL ASSETS
Total Short-Term Assets $1.619B $1.842B
Total Long-Term Assets $1.453B $1.120B
Total Assets $3.071B $2.961B
YoY Change 17.4% 25.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $32.67M $30.57M
YoY Change 34.66% 49.5%
Accrued Expenses $162.4M $147.3M
YoY Change -28.22% -7.57%
Deferred Revenue $7.488M $6.932M
YoY Change -4.17% 9.79%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $324.4M $301.7M
YoY Change -3.92% 18.18%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $61.95M $1.908M
YoY Change 672.17% -73.01%
Total Long-Term Liabilities $61.95M $1.908M
YoY Change 672.17% -73.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $324.4M $301.7M
Total Long-Term Liabilities $61.95M $1.908M
Total Liabilities $583.1M $470.0M
YoY Change 43.74% 44.97%
SHAREHOLDERS EQUITY
Retained Earnings -$34.23M -$4.052M
YoY Change -84.19% -98.84%
Common Stock $324.0K $323.0K
YoY Change 1.57% 2.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.488B $2.491B
YoY Change
Total Liabilities & Shareholders Equity $3.071B $2.961B
YoY Change 17.4% 25.1%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$30.17M $73.21M
YoY Change -178.98% -23.81%
Depreciation, Depletion And Amortization $5.946M $5.663M
YoY Change 207.92% 17.88%
Cash From Operating Activities $73.69M $110.1M
YoY Change -23.6% 32.13%
INVESTING ACTIVITIES
Capital Expenditures $1.717M -$8.043M
YoY Change -110.76% -44.52%
Acquisitions
YoY Change
Other Investing Activities -$244.1M -$60.91M
YoY Change -8501.55% 803.41%
Cash From Investing Activities -$245.8M -$68.95M
YoY Change 1782.67% 224.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.003M -2.038M
YoY Change -88.87% -29.26%
NET CHANGE
Cash From Operating Activities 73.69M 110.1M
Cash From Investing Activities -245.8M -68.95M
Cash From Financing Activities -2.003M -2.038M
Net Change In Cash -174.1M 39.08M
YoY Change -366.18% -33.97%
FREE CASH FLOW
Cash From Operating Activities $73.69M $110.1M
Capital Expenditures $1.717M -$8.043M
Free Cash Flow $71.98M $118.1M
YoY Change -35.97% 20.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Local Phone Number
LocalPhoneNumber
837-7000
exel Number Of Countries With Drug Approval Excluding The Us
NumberOfCountriesWithDrugApprovalExcludingTheUS
62 country
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000939767
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-30235
dei Entity Registrant Name
EntityRegistrantName
EXELIXIS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3257395
dei Entity Address Address Line1
EntityAddressAddressLine1
1851 Harbor Bay Parkway
dei Entity Address City Or Town
EntityAddressCityOrTown
Alameda,
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94502
dei City Area Code
CityAreaCode
650
dei Security12b Title
Security12bTitle
Common Stock $.001 Par Value per Share
dei Trading Symbol
TradingSymbol
EXEL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
322561418 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
675286000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
647169000 usd
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
871706000 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
819905000 usd
CY2022Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
215015000 usd
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
282650000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
26711000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
27493000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
52903000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
57530000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1841621000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1834747000 usd
CY2022Q3 us-gaap Long Term Investments
LongTermInvestments
551735000 usd
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
371112000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
107909000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
104031000 usd
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
116415000 usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
111663000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
63684000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
63684000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
280008000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
131002000 usd
CY2022Q3 us-gaap Assets
Assets
2961372000 usd
CY2021Q4 us-gaap Assets
Assets
2616239000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
30572000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
24258000 usd
CY2022Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
66927000 usd
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
61969000 usd
CY2022Q3 exel Accrued Clinical Liabilities Current
AccruedClinicalLiabilitiesCurrent
62057000 usd
CY2021Q4 exel Accrued Clinical Liabilities Current
AccruedClinicalLiabilitiesCurrent
77544000 usd
CY2022Q3 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
43791000 usd
CY2021Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
33700000 usd
CY2022Q3 exel Accrued Collaboration Liability Current
AccruedCollaborationLiabilityCurrent
18277000 usd
CY2021Q4 exel Accrued Collaboration Liability Current
AccruedCollaborationLiabilityCurrent
86753000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
80109000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
53366000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
301733000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
337590000 usd
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
6491000 usd
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
8739000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
159838000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
51272000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1908000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8023000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
469970000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
405624000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
322541000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
322541000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
318842000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
318842000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
323000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
319000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2512669000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2427561000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17538000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-758000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4052000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-216507000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2491402000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2210615000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2961372000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2616239000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
411738000 usd
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
328423000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1187145000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
983830000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15305000 usd
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11874000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
41989000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39956000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
198837000 usd
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
163370000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
554989000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
471448000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
114983000 usd
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
101558000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
340605000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
302404000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
329125000 usd
CY2021Q4 us-gaap Costs And Expenses
CostsAndExpenses
276802000 usd
us-gaap Costs And Expenses
CostsAndExpenses
937583000 usd
us-gaap Costs And Expenses
CostsAndExpenses
813808000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
82613000 usd
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
51621000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
249562000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
170022000 usd
CY2022Q3 us-gaap Interest Income Other
InterestIncomeOther
9498000 usd
CY2021Q4 us-gaap Interest Income Other
InterestIncomeOther
1658000 usd
us-gaap Interest Income Other
InterestIncomeOther
16077000 usd
us-gaap Interest Income Other
InterestIncomeOther
6231000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-69000 usd
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
140000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-120000 usd
CY2022Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
92042000 usd
CY2021Q4 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
53260000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
265779000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
176133000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18832000 usd
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15056000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
53324000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40236000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
73210000 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
38204000 usd
us-gaap Net Income Loss
NetIncomeLoss
212455000 usd
us-gaap Net Income Loss
NetIncomeLoss
135897000 usd
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
322148000 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
315380000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
320949000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
313990000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
325066000 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
322022000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
324420000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
322084000 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
73210000 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
38204000 usd
us-gaap Net Income Loss
NetIncomeLoss
212455000 usd
us-gaap Net Income Loss
NetIncomeLoss
135897000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
2457000 usd
CY2021Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
193000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
4752000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
949000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-8621000 usd
CY2021Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-504000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-16780000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2995000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
64589000 usd
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
37700000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
195675000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
132902000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2391260000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
73210000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-8621000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2848000 usd
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4906000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
37611000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2491402000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
2043077000 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
38204000 usd
CY2021Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-504000 usd
CY2021Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3305000 usd
CY2021Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
5958000 usd
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34323000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2112447000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2210615000 usd
us-gaap Net Income Loss
NetIncomeLoss
212455000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-16780000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
18680000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
16091000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
82523000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2491402000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1879113000 usd
us-gaap Net Income Loss
NetIncomeLoss
135897000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2995000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
18792000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
15371000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
97011000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2112447000 usd
us-gaap Net Income Loss
NetIncomeLoss
212455000 usd
us-gaap Net Income Loss
NetIncomeLoss
135897000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14929000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11699000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
81718000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
96654000 usd
exel Noncash Lease Expense
NoncashLeaseExpense
11931000 usd
exel Noncash Lease Expense
NoncashLeaseExpense
3952000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-32365000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-7390000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-35871000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-66890000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20124000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9836000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
26956000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
35166000 usd
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
19.99
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
24252000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3130000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
11434000 usd
exel Increase Decrease In Accrued Collaboration Liabilities
IncreaseDecreaseInAccruedCollaborationLiabilities
-64976000 usd
exel Increase Decrease In Accrued Collaboration Liabilities
IncreaseDecreaseInAccruedCollaborationLiabilities
13947000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6715000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
33865000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
288920000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
304352000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25989000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
48265000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1079411000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1077377000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
826768000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1095813000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-278632000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.36
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29829000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
18680000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
18242000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
16091000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15049000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2589000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3193000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12877000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
277716000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
663891000 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
320772000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
676768000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
598488000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
121958000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4893000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1643000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5143000 usd
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
500000 usd
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
9000000 usd
us-gaap Fiscal Period
FiscalPeriod
<span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a 52- or 53-week fiscal year policy that generally ends on the Friday closest to December 31</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span>. Fiscal year 2022, which is a 52-week fiscal year, will end on December 30, 2022 and fiscal year 2021, which was a 52-week fiscal year, ended on December 31, 2021. For convenience, references in this report as of and for the fiscal period ended October 1, 2021, and as of and for the fiscal year ending December 30, 2022 are indicated as being as of and for the period ended September 30, 2021, and the year ending December 31, 2022, respectively.
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2022Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
65189000 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1809568000 usd
us-gaap Use Of Estimates
UseOfEstimates
The preparation of the accompanying Condensed Consolidated Financial Statements conforms to accounting principles generally accepted in the U.S., which requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. On an ongoing basis, we evaluate our significant estimates. We base our estimates on historical experience and on various other market-specific and other relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates.
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Certain prior period amounts in the accompanying Condensed Consolidated Financial Statements have been reclassified to conform to the current period presentation. Such reclassifications did not impact previously reported total revenues, income from operations, net income, total assets, total liabilities or total stockholders’ equity.
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
411738000 usd
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
328423000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1187145000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
983830000 usd
CY2021Q2 exel Loss Contingency Number Of Lawsuits Consolidated
LossContingencyNumberOfLawsuitsConsolidated
2 lawsuit
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
411738000 usd
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
328423000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1187145000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
983830000 usd
CY2021Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
48325000 usd
exel Valuation Allowances And Reserves Additions For Sales In Current Period
ValuationAllowancesAndReservesAdditionsForSalesInCurrentPeriod
403270000 usd
exel Valuation Allowances And Reserves Additions For Sales In Prior Period
ValuationAllowancesAndReservesAdditionsForSalesInPriorPeriod
357000 usd
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
386763000 usd
CY2022Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
364000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1665000 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6932000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7814000 usd
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
6491000 usd
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
8739000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13423000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
16553000 usd
exel Contract With Customer Liability Including New Contract Revenue Recognized
ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized
6600000 usd
exel Contract With Customer Liability Including New Contract Revenue Recognized
ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized
6800000 usd
CY2022Q3 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
33900000 usd
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
125000000 usd
CY2021Q4 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
48400000 usd
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
116200000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
675286000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
647169000 usd
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1482000 usd
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
16722000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
676768000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
663891000 usd
CY2022Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1831896000 usd
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
22328000 usd
CY2022Q3 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Amortized Cost Basis
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
2122537000 usd
CY2022Q3 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2022Q3 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
22328000 usd
CY2022Q3 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecurities
2100209000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1534464000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
934000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1730000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1533668000 usd
CY2021Q4 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Amortized Cost Basis
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
1855704000 usd
CY2021Q4 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
934000 usd
CY2021Q4 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1730000 usd
CY2021Q4 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecurities
1854908000 usd
CY2022Q3 us-gaap Interest Receivable
InterestReceivable
4800000 usd
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
2900000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
967168000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
588862 shares
CY2022Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
22328000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
454780000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
1730000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
276 investment
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
133 investment
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
64000000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
2400000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1260834000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1168256000 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
548734000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
365412000 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1809568000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1533668000 usd
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
9447000 usd
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
8867000 usd
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
39380000 usd
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
27717000 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11325000 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12927000 usd
CY2022Q3 us-gaap Inventory Gross
InventoryGross
60152000 usd
CY2021Q4 us-gaap Inventory Gross
InventoryGross
49511000 usd
CY2022Q3 us-gaap Inventory Gross
InventoryGross
60152000 usd
CY2021Q4 us-gaap Inventory Gross
InventoryGross
49511000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
37337000 usd
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33966000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
81718000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
96654000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
37337000 usd
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33966000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
81718000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
96654000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
28500000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
31485656 shares
exel Share Based Compensation Arrangement By Share Based Payment Award Reduction In Share Reserve Due To Stock Option Or Stock Appreciation Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardReductionInShareReserveDueToStockOptionOrStockAppreciationAward
1 shares
exel Share Based Compensation Arrangement By Share Based Payment Award Reduction In Share Reserve Due To Other Awards
ShareBasedCompensationArrangementByShareBasedPaymentAwardReductionInShareReserveDueToOtherAwards
2 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11416151 shares
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
19600000 usd
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.205
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.201
CY2021Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.283
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.228
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
73210000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
73210000 usd
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
38204000 usd
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
38204000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
212455000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
212455000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
135897000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
135897000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
322148000 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
315380000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
320949000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
313990000 shares
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2918000 shares
CY2021Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6642000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3471000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
8094000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
325066000 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
322022000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
324420000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
322084000 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.050
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
4300000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4300000 usd
CY2022Q3 exel Loss Contingency Number Of Lawsuits Consolidated
LossContingencyNumberOfLawsuitsConsolidated
2 lawsuit

Files In Submission

Name View Source Status
exel-20220930_pre.xml Edgar Link unprocessable
exel-20220930_cal.xml Edgar Link unprocessable
exel-20220930_htm.xml Edgar Link completed
0000939767-22-000110-index-headers.html Edgar Link pending
exel-20220930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0000939767-22-000110-index.html Edgar Link pending
0000939767-22-000110.txt Edgar Link pending
0000939767-22-000110-xbrl.zip Edgar Link pending
exel-20220930.htm Edgar Link pending
exel-20220930.xsd Edgar Link pending
exel-20220930_g1.jpg Edgar Link pending
exel20220930exhibit31110q.htm Edgar Link pending
exel20220930exhibit31210q.htm Edgar Link pending
exel20220930exhibit32110q.htm Edgar Link pending
exel2022930exhibit10110q.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
exel-20220930_lab.xml Edgar Link unprocessable